| Product NDC: | 65862-288 |
| Proprietary Name: | Perindopril Erbumine |
| Non Proprietary Name: | Perindopril Erbumine |
| Active Ingredient(s): | 8 mg/1 & nbsp; Perindopril Erbumine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-288 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079070 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091110 |
| Package NDC: | 65862-288-59 |
| Package Description: | 5000 TABLET in 1 BAG (65862-288-59) |
| NDC Code | 65862-288-59 |
| Proprietary Name | Perindopril Erbumine |
| Package Description | 5000 TABLET in 1 BAG (65862-288-59) |
| Product NDC | 65862-288 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Perindopril Erbumine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20091110 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | PERINDOPRIL ERBUMINE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |